BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21352754)

  • 21. Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
    Ajelli M; Merler S; Pugliese A; Rizzo C
    Epidemiol Infect; 2011 Jan; 139(1):68-79. PubMed ID: 20546633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic.
    Sharomi O; Podder CN; Gumel AB; Mahmud SM; Rubinstein E
    Bull Math Biol; 2011 Mar; 73(3):515-48. PubMed ID: 20379852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The strategy against influenza].
    Labro MT; Etiemble J
    Rev Prat; 2010 Jan; 60(1):81-92. PubMed ID: 20222318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic (avian) influenza.
    Rajagopal S; Treanor J
    Semin Respir Crit Care Med; 2007 Apr; 28(2):159-70. PubMed ID: 17458770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of neuraminidase inhibitors to combat pandemic influenza.
    Democratis J; Pareek M; Stephenson I
    J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza: current threat from avian influenza.
    Stephenson I; Democratis J
    Br Med Bull; 2005; 75-76():63-80. PubMed ID: 16651383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modelling the impact of pandemic influenza].
    Chun BC
    J Prev Med Public Health; 2005 Nov; 38(4):379-85. PubMed ID: 16358821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A note on the use of influenza vaccination strategies when supply is limited.
    Lee S; Morales R; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to review New Zealand's antiviral stockpile for pandemic preparedness?
    Wilson N; Baker MG
    N Z Med J; 2014 Jun; 127(1396):87-9. PubMed ID: 24997469
    [No Abstract]   [Full Text] [Related]  

  • 33. A model for influenza with vaccination and antiviral treatment.
    Arino J; Brauer F; van den Driessche P; Watmough J; Wu J
    J Theor Biol; 2008 Jul; 253(1):118-30. PubMed ID: 18402981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
    Ward P; Small I; Smith J; Suter P; Dutkowski R
    J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
    Postma MJ; Milne G; Nelson EA; Pyenson B; Basili M; Coker R; Oxford J; Garrison LP;
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1431-9. PubMed ID: 21133667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on preparing for the next influenza pandemic.
    Weber CJ
    Urol Nurs; 2006 Apr; 26(2):145-8. PubMed ID: 16703923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience from influenza A (H1N1) pandemic 2009--is prevention better than cure?
    Parikh FS
    J Assoc Physicians India; 2011 Jan; 59():11-2. PubMed ID: 21751658
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
    Dimitrov NB; Goll S; Hupert N; Pourbohloul B; Meyers LA
    PLoS One; 2011 Jan; 6(1):e16094. PubMed ID: 21283514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.
    Moss R; McCaw JM; Cheng AC; Hurt AC; McVernon J
    BMC Infect Dis; 2016 Oct; 16(1):552. PubMed ID: 27724915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of school closures on pandemic influenza: Assessing potential repercussions using a seasonal SIR model.
    Towers S; Geisse KV; Tsai CC; Han Q; Feng Z
    Math Biosci Eng; 2012 Apr; 9(2):413-30. PubMed ID: 22901071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.